Why Your Skincare Routine Is an Economic Decision

I’ll be honest: I’ve spent an embarrassing amount of time thinking about skincare. Not just what to put on my face, but whya nearly identical moisturizer costs $8 at CVS and $345 at Nordstrom. The global beauty market hit about $670 billion in 2025, according to Statista. That’s roughly the GDP of Sweden. And once you start pulling at the thread of how that money flows, the whole thing unravels in the most fascinating way.

I know this industry from the consumer side. I’ve tried products across every price point, read ingredient lists obsessively, tracked how my skin responds to specific actives over months. My roommate thinks it’s unhinged. She’s probably right. But that personal knowledge is exactly what made me start asking economic questions, because once you understand what’s actually ina moisturizer, you realize the pricing has almost nothing to do with what’s inside the jar.

The La Mer Problem

La Mer’s Crème de la Mer. Two ounces. $345. According to a Business Insider investigation, the estimated production cost for a 3.4-ounce bottle is about $35. That’s a 10:1 markup. The ingredients doing the actual moisturizing—glycerin and mineral oil—are the same stuff in Nivea ($4) and CeraVe ($16). La Mer’s proprietary “Miracle Broth” is built around seaweed extract, which is neither rare nor expensive.

That’s a $310 surcharge for vibes.

Dermatologists have been saying this for years. But the market doesn’t care what dermatologists say, because La Mer isn’t selling moisturizer. It’s selling exclusivity, ritual, and the psychological comfort of luxury. The packaging, the heritage story about a NASA physicist healing his burns, the celebrity endorsements—that’s all part of a carefully constructed perceived value. In economics terms, it’s textbook price discrimination: La Mer targets consumers with high willingness to pay and low price sensitivity. CeraVe targets everyone else. Both products moisturize skin. The price gap is almost entirely branding.

Then The Ordinary Showed Up and Broke Everything

In 2016, Brandon Truaxe launched The Ordinary with a genuinely radical premise: sell clinical-grade skincare at near-cost pricing with transparent labeling. Niacinamide 10% + Zinc 1% for $6. Hyaluronic Acid 2% + B5 for $8. These are the same actives other brands wrap in $60-$120 serums. The Ordinary just stripped out the marketing budget and passed the savings through.

The results were wild. DECIEM (The Ordinary’s parent company) was valued at over $2.2 billion when Estée Lauder completed the full acquisition in 2024. The Ordinary’s e-commerce alone went from $113 million in 2024 to $213 million in 2025. What they exposed was something the industry had been hiding: ingredient commoditization. Hyaluronic acid is hyaluronic acid. Retinol is retinol. The raw materials are globally traded commodities that cost pennies per unit. When you could suddenly buy niacinamide for $6 instead of $60, a lot of people realized they’d been paying a 90% premium for packaging and a brand name.

But here’s the thing that complicates the narrative: The Ordinary didn’t kill luxury skincare. L’Oréal reported 43.48 billion euros in revenue in 2024, up 5.6%. Estée Lauder maintained its whole portfolio of luxury brands at premium prices. Both cheap and expensive skincare grew simultaneously. Which tells you this isn’t one market. It’s several overlapping markets segmented by consumer psychology as much as product performance.

The Ordinary proved that the ingredients are cheap. The luxury market proved that nobody cares.

The “Clean Beauty” Scam (Sort Of)

Okay, “scam” is too strong. But the clean beauty movement is genuinely one of the most interesting pricing phenomena I’ve come across. The market was valued at $8-9 billion in 2024 and is projected to hit $33 billion by 2034 (Grand View Research). Brands like Drunk Elephant, Tata Harper, and Ilia charge premium prices for formulations that exclude parabens, sulfates, and synthetic fragrances.

The thing is, the premium isn’t really about ingredient costs. Many “clean” ingredients aren’t more expensive than conventional ones. What you’re paying for is the marketing cost of convincing you to fear specific ingredients, the certification overhead, and the brand positioning. And here’s the kicker: parabens, one of the most demonized preservative classes, have been reviewed by both the FDA and the European Commission’s Scientific Committee on Consumer Safety. Both concluded parabens are safe at the concentrations used in cosmetics.

So consumers are paying more to avoid ingredients that regulated bodies consider safe. I’m not saying clean beauty hasn’t done good things—it’s pushed transparency and ingredient awareness forward. But the pricing structure is built on subtraction, not addition. You’re paying for what’s notin the bottle. That gap between perception and scientific evidence is where the premium lives, and I think that’s worth being honest about.

How Marketing Eats Everything

Most consumers can’t evaluate whether a product’s active ingredients are at effective concentrations, whether the formulation is stable, or whether the delivery system actually penetrates the skin barrier. So they use proxies: brand reputation, price (higher must mean better), packaging, influencer recommendations. This creates a market where signaling dominates substance. A brand can charge $120 for a vitamin C serum with the same L-ascorbic acid concentration as a $15 alternative and succeed, because the price itself signals quality. Behavioral economists call this the price-quality heuristic, and in skincare—where results take weeks, are influenced by a million confounding variables—it’s incredibly powerful.

Social media makes it worse. When a creator with a million followers says a $48 moisturizer “changed her skin,” you’re not just buying moisturizer. You’re buying into her lifestyle. Influencer marketing hit $24 billion in 2024, and beauty is one of its biggest verticals. It’s marketing at its most efficient because it doesn’t feel like marketing.

The Retinol Price Ladder Is Absurd

I think the retinol market is the single best illustration of price discrimination in consumer goods. The Ordinary Retinol 0.5% in Squalane: $6. Drunk Elephant A-Passioni Retinol Cream: $74. SkinCeuticals Retinol 0.5: $88. La Prairie Skin Caviar Nighttime Oil with retinol: $480. All four contain retinol as the primary active. The 80x price variation tells you everything you need to know about what’s actually driving the price: it’s not the retinol.

Each brand targets a completely different person. The Ordinary goes after informed, price-sensitive buyers who research ingredients. Drunk Elephant wants the “clean” crowd who care about Instagram-worthy packaging. SkinCeuticals targets people who trust dermatologist recommendations. La Prairie targets people for whom the price is the point. Same active ingredient, four different consumer psychologies, four wildly different prices. Classic third-degree price discrimination.

What I Actually Think

This is the most interesting thing I’ve studied this year, and it’s partly because skincare is one of the few industries where I have enough domain knowledge to see through the marketing. I know what niacinamide does. I know what concentration of retinol is effective. I know the seaweed in La Mer isn’t meaningfully different from the seaweed in a $20 Korean sheet mask. That knowledge doesn’t make me immune to beautiful packaging or a convincing influencer rec—I still get tempted. But it does make me think about what I’m actually paying for every time I add something to my cart.

The beauty industry is a $670 billion case study in behavioral economics and the power of narrative to shape markets. Every product on your bathroom shelf represents a series of economic choices about how much you value ingredients versus branding, evidence versus marketing, genuine need versus social influence. You don’t have to buy the cheapest option. But you should at least know what you’re paying for.